95 related articles for article (PubMed ID: 28934903)
21. Inhibition of Rac activity alleviates lipopolysaccharide-induced acute pulmonary injury in mice.
Yao HY; Chen L; Xu C; Wang J; Chen J; Xie QM; Wu X; Yan XF
Biochim Biophys Acta; 2011 Jul; 1810(7):666-74. PubMed ID: 21511011
[TBL] [Abstract][Full Text] [Related]
22. Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene.
Wang PL; Niidome T; Akaike A; Kihara T; Sugimoto H
J Neurosci Res; 2009 Jul; 87(9):2105-14. PubMed ID: 19267423
[TBL] [Abstract][Full Text] [Related]
23. Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas.
Kukutla P; Ahmed SG; DuBreuil DM; Abdelnabi A; Cetinbas M; Fulci G; Aldikacti B; Stemmer-Rachamimov A; Plotkin SR; Wainger B; Sadreyev RI; Brenner GJ
Ann Clin Transl Neurol; 2021 Jul; 8(7):1508-1514. PubMed ID: 34053190
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864.
Wang Y; Kunit T; Ciotkowska A; Rutz B; Schreiber A; Strittmatter F; Waidelich R; Liu C; Stief CG; Gratzke C; Hennenberg M
Br J Pharmacol; 2015 Jun; 172(11):2905-17. PubMed ID: 25631101
[TBL] [Abstract][Full Text] [Related]
25. Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1.
Troutman S; Moleirinho S; Kota S; Nettles K; Fallahi M; Johnson GL; Kissil JL
Oncotarget; 2016 Aug; 7(34):54515-54525. PubMed ID: 27363027
[TBL] [Abstract][Full Text] [Related]
26. Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2.
Hung G; Li X; Faudoa R; Xeu Z; Kluwe L; Rhim JS; Slattery W; Lim D
Int J Oncol; 2002 Mar; 20(3):475-82. PubMed ID: 11836557
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation.
Fraenzer JT; Pan H; Minimo L; Smith GM; Knauer D; Hung G
Int J Oncol; 2003 Dec; 23(6):1493-500. PubMed ID: 14612918
[TBL] [Abstract][Full Text] [Related]
28. Establishment of primary vestibular schwannoma cultures from neurofibromatosis type-2 patients.
Hung G; Faudoa R; Li X; Xeu Z; Brackmann DE; Hitselberg W; Saleh E; Lee F; Gutmann DH; Slattery W; Rhim JS; Lim D
Int J Oncol; 1999 Mar; 14(3):409-15. PubMed ID: 10024671
[TBL] [Abstract][Full Text] [Related]
29. Downregulated Rac1 promotes apoptosis and inhibits the clearance of apoptotic cells in airway epithelial cells, which may be associated with airway hyper-responsiveness in asthma.
Wan J; Cao Y; Abdelaziz MH; Huang L; Kesavan DK; Su Z; Wang S; Xu H
Scand J Immunol; 2019 May; 89(5):e12752. PubMed ID: 30681176
[TBL] [Abstract][Full Text] [Related]
30. CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells.
Huegel J; Dinh CT; Martinelli M; Bracho O; Rosario R; Hardin H; Estivill M; Griswold A; Gultekin S; Liu XZ; Fernandez-Valle C
Oncotarget; 2022; 13():890-904. PubMed ID: 35875610
[TBL] [Abstract][Full Text] [Related]
31. Novel patient-derived xenograft and cell line models for therapeutic screening in NF2-associated schwannoma.
Zhao F; Chen Y; Li SW; Zhang J; Zhang S; Zhao XB; Yang ZJ; Wang B; He QY; Wang LM; Xu L; Liu PN
J Pathol; 2022 Aug; 257(5):620-634. PubMed ID: 35394061
[TBL] [Abstract][Full Text] [Related]
32. Loss of NF2 Induces TGFβ Receptor 1-mediated Noncanonical and Oncogenic TGFβ Signaling: Implication of the Therapeutic Effect of TGFβ Receptor 1 Inhibitor on NF2 Syndrome.
Cho JH; Oh AY; Park S; Kang SM; Yoon MH; Woo TG; Hong SD; Hwang J; Ha NC; Lee HY; Park BJ
Mol Cancer Ther; 2018 Nov; 17(11):2271-2284. PubMed ID: 30135214
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous Interference with HER1/EGFR and RAC1 Signaling Drives Cytostasis and Suppression of Survivin in Human Glioma Cells in Vitro.
Karpel-Massler G; Westhoff MA; Kast RE; Dwucet A; Karpel-Massler S; Nonnenmacher L; Siegelin MD; Wirtz CR; Debatin KM; Halatsch ME
Neurochem Res; 2017 May; 42(5):1543-1554. PubMed ID: 28271323
[TBL] [Abstract][Full Text] [Related]
34. Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma.
Bhattacharyya S; Oblinger JL; Beauchamp RL; Yin Z; Erdin S; Koundinya P; Ware AD; Ferrer M; Jordan JT; Plotkin SR; Xu L; Chang LS; Ramesh V
Neuro Oncol; 2023 Sep; 25(9):1617-1630. PubMed ID: 36806881
[TBL] [Abstract][Full Text] [Related]
35. Comparison of outcomes of peripheral nerve schwannoma excision in neurofibromatosis type 2 patients and non-neurofibromatosis type 2 patients: A case control study.
Bendon CL; Furniss D; Giele HP
J Plast Reconstr Aesthet Surg; 2015 Sep; 68(9):1199-203. PubMed ID: 26139580
[TBL] [Abstract][Full Text] [Related]
36. Regulatory effect of Rac1 on vascular reactivity after hemorrhagic shock in rats.
Li T; Yang G; Xu J; Zhu Y; Liu L
J Cardiovasc Pharmacol; 2011 Jun; 57(6):656-65. PubMed ID: 21386710
[TBL] [Abstract][Full Text] [Related]
37. A bidirectional effect of Rac1 inhibition-Protects radiation-induced intestinal injury while inhibits tumor.
An N; Liu T; Zhu B; Yang Y; Yan X; Cao M; Chen Y; Liu R; Xia P; Liu C; Du J; Gao F; Yuan H; Liu H; Cai J
Life Sci; 2020 Jan; 240():117105. PubMed ID: 31786196
[TBL] [Abstract][Full Text] [Related]
38. Human schwannomas express activated platelet-derived growth factor receptors and c-kit and are growth inhibited by Gleevec (Imatinib Mesylate).
Mukherjee J; Kamnasaran D; Balasubramaniam A; Radovanovic I; Zadeh G; Kiehl TR; Guha A
Cancer Res; 2009 Jun; 69(12):5099-107. PubMed ID: 19509233
[TBL] [Abstract][Full Text] [Related]
39. The importance of nerve microenvironment for schwannoma development.
Schulz A; Büttner R; Hagel C; Baader SL; Kluwe L; Salamon J; Mautner VF; Mindos T; Parkinson DB; Gehlhausen JR; Clapp DW; Morrison H
Acta Neuropathol; 2016 Aug; 132(2):289-307. PubMed ID: 27236462
[TBL] [Abstract][Full Text] [Related]
40. Rac1-Mediated DNA Damage and Inflammation Promote Nf2 Tumorigenesis but Also Limit Cell-Cycle Progression.
Shi Y; Bollam SR; White SM; Laughlin SZ; Graham GT; Wadhwa M; Chen H; Nguyen C; Vitte J; Giovannini M; Toretsky J; Yi C
Dev Cell; 2016 Nov; 39(4):452-465. PubMed ID: 27818180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
